STERIS
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Techno...
Latest News
3 days ago · zacks.com
STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock?STE's second-quarter fiscal 2027 earnings may benefit from Healthcare growth, recent acquisitions, easing AST comparisons and continued margin expansion.
4 days ago · globenewswire.com
STERIS Announces Dividend of $0.69 per shareDUBLIN, IRELAND, Oct. 28, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.69 per share. The dividend is payable on December 17, 2026, to shareholders of record at the close of business on November 17, 2026.
11 days ago · gurufocus.com
Steris PLC (STE) Shares Surge 4.8% -- What GF Score of 90 Tells InvestorsOn October 22, 2026, Steris PLC (STE) shares rose 4.8% to $232.22, marking a notable increase today. The stock has fluctuated between a 52-week high of $269.44
13 days ago · globenewswire.com
STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026DUBLIN, IRELAND, Oct. 20, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 second quarter results at 9:00 a.m. ET on November 5, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
17 days ago · zacks.com
Reasons to Add STE Stock to Your Portfolio Right NowSTERIS' strong Healthcare growth, improving AST prospects and rising Life Sciences demand bolster its outlook, despite tariff and inflationary pressures.
21 days ago · gurufocus.com
Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)PR NewswirePITTSBURGH, Oct. 12, 2026PITTSBURGH, Oct. 12, 2026 /PRNewswire/ -- Xodus Medica
21 days ago · wsj.com
Steris to Acquire Xodus Medical for $2.1 BillionThe Dublin, Ireland provider of products and services to hospitals and pharmaceutical manufacturers said it expects the deal to expand its portfolio.
2 months ago · seekingalpha.com
STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSTERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
2 months ago · globenewswire.com
STERIS to Present at the Morgan Stanley Healthcare ConferenceDublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2026.
2 months ago · zacks.com
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove STE